Feedback / Questions
samuraciclib (CT7001) - Carrick Therap
https://www.globenewswire.com/news-release/2025/12/10/3203450/0/en/Carrick-Therapeutics-Announces-Positive-Results-from-Phase-2-Randomized-Trial-of-Samuraciclib-in-Combination-with-Fulvestrant-in-Patients-with-Hormone-Receptor-Positive-HER2-Negati.html
Dec 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next